(Q38461620)
Statements
1 reference
A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer (English)
1 reference
Ko YJ
1 reference
Small EJ
1 reference
Kabbinavar F
1 reference
Chachoua A
1 reference
Taneja S
1 reference
Reese D
1 reference
DePaoli A
1 reference
Hannah A
1 reference
Balk SP
1 reference
Bubley GJ
1 reference
1 April 2001
1 reference
1 reference